1. LIVER CANCER-SPECIFIC BIOMARKER (KR 10-2180117)
2. 肝癌特异性生物标志物 (CN ZL201980053149.7)
3. COMPOSITION FOR PREVENTING OR TREATING LIVER CANCER COMPRISING BANF1, PLOD3 OR SF3B4 INHIBITOR AS ACTIVE INGREDIENT (KR 10-2270926)
4. LIVER CANCER-SPECIFIC BIOMARKERS AND USE THEREOF (KR 10-2023-0064729)
5. PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING LIVER CANCER COMPRISING A GAS5 AND SMARCA4 INHIBITOR AS AN ACTIVE INGREDIENT (KR 10-2930473)
6. COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING AN MSH2 INHIBITOR AS AN ACTIVE INGREDIENT (KR 10-2022-0070947)
7. COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING AN MSH6 INHIBITOR AS AN ACTIVE INGREDIENT (KR 10-2022-0070948)
8. COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING MSH2 OR MSH6 INHIBITOR AS ACTIVE INGREDIENT (US 18682165)
9. COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING MSH2 OR MSH6 INHIBITOR AS ACTIVE INGREDIENT (EU 22856165.0)
10. 包含MSH2或MSH6抑制剂作为有效成分的用于预防或治疗癌症的组合物 (CN 202280054930.8)
11. ＭＳＨ２またはＭＳＨ６抑制剤を有効成分として含む癌予防または治療用組成物 (JP 2024-508093)
12. COMPOSITION FOR THE PREVENTION OR TREATMENT OF LIVER CANCER (KR 10-2344598)
13. COMPOSITION FOR PREVENTING OR TREATING LIVER CANCER, COMPRISING TSP1 AS AN ACTIVE INGREDIENT (KR 10-2576855)
14. COMPOSITION FOR THE PREVENTION OR TREATMENT OF LIVER CANCER COMPRISING MODIFIED RT-LET7 AS AN ACTIVE INGREDIENT (KR 10-2329524)
15. DELIVERY SYSTEM FOR THE PREVENTION OR TREATMENT OF LIVER CANCER INCLUDING MODIFIED RT-LET7 AS AN ACTIVE INGREDIENT (KR 10-2428121)
16. DELIVERY SYSTEM FOR THE PREVENTION OR TREATMENT OF CANCER CONTAINING MODIFIED RT-LET7 AS AN ACTIVE INGREDIENT (KR 10-2771160)
17. COMPOSITION FOR PREVENTION OR TREATMENT OF LIVER CANCER, COMPRISING MODIFIED RT-LET7 AS ACTIVE INGREDIENT (US 18681745)
18. COMPOSITION FOR PREVENTION OR TREATMENT OF LIVER CANCER, COMPRISING MODIFIED RT-LET7 AS ACTIVE INGREDIENT (EU 22853368.3)
19. 包含修饰的RT-LET7作为有效成分的用于预防或治疗肝癌的组合物 (CN 202280054494.4)
20. 変形されたＲＴ－ＬＥＴ７を有効成分として含む肝癌の予防または治療用組成物 (JP 7766375)
21. COMPOSITION FOR PREVENTION OR TREATMENT OF LIVER CANCER, COMPRISING MODIFIED RT-LET7 AS ACTIVE INGREDIENT (CA 3228077)
22. COMPOSITION FOR PREVENTION OR TREATMENT OF LIVER CANCER, COMPRISING MODIFIED RT-LET7 AS ACTIVE INGREDIENT (AU 2022324176)
23. GKN1(GASTROKINE 1) SPECIFIC ANTIBODY AND USE THEREOF (KR 10-2590757)
24. GASTROKINE 1 SPECIFIC ANTIBODY AND USE THEREOF (KR 10-2022-0140869)
25. COMPOUND COMPRISING A MODIFIED MIRNA INHIBITING LET-7I-5P EXPRESSION CONJUGATED WITH A HEPATOCYTE-TARGETING MOIETY FOR THE PREVENTION OR TREATMENT OF METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS AND LIVER FIBROSIS (KR 10-2026-0042454)
26. Method for diagnosing gastric cancer using C8 and H7 antibodies and uses thereof (KR 10-2026-0066309)